［1］Torre LA,Bray F,Sieqel RL,et al.Global cancer statistics［J］.CA Cancer J Clin,2015,65(2):87-108.
［2］Stein U,Walther W,Arlt F,et al.MACC1,a newly identified key regulator of HGF-MET signaling,predicts colon cancer metastasis［J］.Nat Med,2009,15:59-67.
［3］Stein U,Smith J,Walther W,et al.MACC1 controls Met - what a difference an Sp1 site- makes［J］.Cell Cycle,2009,8:2467-2469.
［4］Juneja M,Im K,Schlag PM,et al.Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer［J］.Mol Oncol,2013,7(5):929-943.
［5］Stein U,Dahlmann M,Wather W,et al.MACC1 - more than metastasis? Facts and predictions about a novel gene［J］.J Mol Med (Berl),2010,88(1):11-18.
［6］Pichorner A,Sack U,Kobelt D,et al.In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice［J］.Clin Exp Metastasis,2012,29(6):573-583.
［7］Zuo X,Gong ZG,Jiang GJ,et al.Investigation of expression of MACC1 and its relationship to invasion,metastasis in squamons cell carcinoma of the esophagus after esophagectomy［J］.Acta Universitatis Medicinalis Nanjing,2014,34(10):1352-1354.［左欣,龚泽刚,蒋国军,等.MACC1 表达与胸中段食管鳞癌侵袭、转移的关系［J］.南京医科大学学报,2014,34(10):1352-1354.］
［8］Zhu MC,Xu YJ,Mao XL,et al.Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patient with esophageal cancer［J］.Pathol Oncol Res,2013,19:749-753.
［9］Zhen T,Dai S,Li H,et al.MACC1 promotes carcinogenesis of colorectal cancer via β-ca-tenin signaling pathway［J］.Oncotarget,2014,5(11):3756-3769.
［10］Ashktorab H,Hermann P,Nouraie M,et al.Increased MACC1levels in tissues and blood identify colon adenoma patients at high risk［J］.J Translational Medicine,2016,14:215-217.
［11］Wang G,Ju HX,Fu ZX,et al.The role of MACC1 in the migration and chemoresistance of colorectal cancer［J］.Chin J Colorectal Diseases(Electronic Edition),2015,4(4):396-400.［王刚,鞠海星,付志璇,等.MACC1在结直肠癌迁移及化疗耐药中的实验研究［J］.中华结直肠疾病电子杂志,2015,4(4):396-400.］
［12］Wang L,Wu Y,Lin L,et al.Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer,and promotes tumour cell proliferation and invasion［J］.Int J Cancer,2013,133:1419-1430.
［13］Wang L,Lin L,Chen X,et al.Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2［J］.Oncotarget,2015,6(13):11492-11506.
［14］Lin L,Huang H,Liao W,et al.MACC1 supports human gastric cancer growth under- metabolic stress by enhancing the warburg effect［J］.Oncogene,2015,34:2700-2710.
［15］Wu ZZ,Li SC,Rui Z,et al.Metastasis-associated in colon cancer-1 in gastric cancer:Beyond metastasis［J］.World J Gastroenterol,2016,22(29):6629-6637.
［16］Sun L,Duan J,Jiang Y,et al.Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer［J］.Cancer Lett,2015,357:242-253.
［17］Burock S,Herrmann P,Wendler I,et al.Circulating metastasis associated in colon cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker［J］.World J Gastroenterol,2015,21:333-341.
［18］Yang T,He W,Cui F,et al.MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells［J］.Oncotarget,2016,7(14):18085-18094.
［19］Gao J,Ding F,Liu Q,et al.Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9［J］.Mol Cell Biochem,2013,376:21-32.
［20］Xie C,Wu J,Yun J,et al.MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma［J］.PLoS One,2013,8:23-29.
［21］Mazzaferro V,Regalia E,Doci R,et al.Liver transplantation for the treatment of small hepatocelluar carcinomas in patients with cirrhosis［J］.The New England J Medicine,1996,334:693-700.
［22］Zimmerman MA,Ghobrial RM,Tong MJ,et al.Recurrence of hepatocellular carcinoma following liver transplantation:A review of preoperative and postoperative prognostic indicators［J］.Arch Surg,2008,143:182-188.
［23］Zheng Z,Gao S,Yang Z,et al.Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transpla-ntation［J］.Int J Med Sci,2014,11:142-150.
［24］Egeblad M,Werb Z,Banach A,et al.New functions for the matrix metalloproteinases in cancer progression［J］.Nat Rev Cancer,2012,2(3):163-174.
［25］Bjorklund M,Koivunen E,Cao J,et al.Gelatinase-mediated migration and invasion of cancer cells［J］.Biochim Biophys Acta,2015,1755(1):37-69.
［26］Canel M,Secades P,Garzon-Arango M,et al.Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression［J］.Br J Cancer,2008,98(7):1274-1284.
［27］Lamar JM,Pumiglia KM,DiPersio CM,et al.An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasion［J］.Cancer Res,2008,68(18):7371-7379.
［28］Zheng H,Takahashi H,Murai Y,et al.Expressions of MMP-2,MMP-9 and VEGF are closely linked to growth,invasion,metastasis and angiogenesis of gastric carcinoma［J］.Anticancer Res,2016,26(5A):3579-3583.
［29］Gao J,Ding F,Liu Q,et al.Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and in-hibited expression of MMP2 and MMP9［J］.Mol Cell Biochem,2012,376:21-32.
［30］Xue H,Sun K,Xie W,et al.Etanercept attenuates short-term cigarette-smoke-exposure-induced pulmonary arterial remodelling in rats by suppressing the activation of TNF-a/NF-kB signal and the activities of MMP-2 and MMP-9［J］.Pulm Pharmacol Ther,2012,25(3):208-215.
［31］Pliarchopoulou K,Pectasides D,Werb Z,et al.Pancreatic cancer:Current and future.Treatment strategies［J］.Cancer Treat Rev,2009,35:431-436.
［32］Deramaudt T,Rustgi A,Annabi B,et al.Mutant KRAS in the initiation of pancreatic cancer［J］.Biochim Biophys Acta,2005,1756:97-101.
［33］Rejiba S,Wack S,Aprahamian M,et al.K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment［J］ .Cancer Sci,2007,98:1128-1136.